Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Lymphoid Enhancer-Binding Factor 1 (LEF1) (Intermediate Domain) Peptid

LEF1 Reaktivität: Human, Maus, Ratte Wirt: Synthetic BP, BI
Produktnummer ABIN5686297
464,75 €
Zzgl. Versandkosten 20,00 € und MwSt
0.1 mg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für Lymphoid Enhancer-Binding Factor 1 (LEF1) (Intermediate Domain) Peptid (ABIN5686297)

Target

LEF1 (Lymphoid Enhancer-Binding Factor 1 (LEF1))

Spezies

Human, Maus, Ratte

Quelle

  • 3
Synthetic

Applikation

Blocking Peptide (BP), BioImaging (BI)
  • Protein Region

    Intermediate Domain

    Produktmerkmale

    LEF1 peptide corresponds to 14 amino acids near the intermediate domain of LEF1.
  • Applikationshinweise

    LEF1 Peptide is used for blocking the activity of LEF1 antibody . The LEF1 antibody ships at 0.5 mg/mL and the LEF1 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    LEF1 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20°C. When reconstituted minimize freezing and thawing.
  • Target

    LEF1 (Lymphoid Enhancer-Binding Factor 1 (LEF1))

    Gen-ID

    51176

    NCBI Accession

    NP_057353

    OMIM

    7705917

    UniProt

    Q9UJU2
Sie sind hier:
Chat with us!